# FDA Inspection 1211565 - Elevate Surgical - July 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/elevate-surgical/6fe92b4e-6911-4fdc-95ff-6e4fb143402f
Source feed: FDA_Inspections

> FDA Inspection 1211565 for Elevate Surgical on July 27, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1211565
- Company Name: Elevate Surgical
- Inspection Date: 2023-07-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1309442 - 2026-03-26](https://www.keypedia.com/records/fda_inspections/elevate-surgical/72b14923-519a-488a-93f0-01a8c394ed55)
- [FDA Inspection 1211565 - 2023-07-27](https://www.keypedia.com/records/fda_inspections/elevate-surgical/3e5bf9ed-7fb3-481d-ad9c-b459dbab7066)
- [FDA Inspection 1064242 - 2018-08-01](https://www.keypedia.com/records/fda_inspections/elevate-surgical/ad9e76e3-f41e-4507-a6af-e1aced252098)

Company: https://www.keypedia.com/companies/elevate-surgical/5a4b8675-fd34-4225-b025-bd9ca7976d35

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d